On April 29, Hybribio donated a batch of COVID-19 diagnostic kits to the Sri Lankan Embassy in China. Mr. K.K.Yeganadan, Acting Ambassador of Sri Lankan Embassy in China, Mr. Guna Sekhor, Minister of Commerce, and their party gave a warm reception.

Mr. K.K.Yeganadan, the acting ambassador of the Sri Lankan Embassy in China, said that these donations are currently the most urgently needed in Sri Lanka, and he is very grateful to Hybribio for its support at such a critical moment in fighting the pandemic. At this challenging time, we will fight in unity and will surely win the epidemic prevention and control. The Commercial Minister of the Embassy of Sri Lanka in China stated that with the spread of the pandemic, the situation of the Sri Lankan epidemic is more serious. They are looking forward to maintaining in-depth communication and carrying out more cooperation in the future.

 Wu Yingzhi, general manager of Hybribio Beijing Branch, said that at the time of the pandemic, Hybribio keeps a close eye on the epidemic situation in various countries around the world. COVID-19 not only poses a threat to the lives and health of the Chinese people but also is a great challenge to the global public health. We would love to provide support and express our blessings to the people of Sri Lanka and overcome the pandemic together. In addition, Chen Jianhua, deputy director of technical support, introduced technical details such as the use of the kit and the interpretation of results. So after the kit arrived at the Sri Lankan laboratory, it could be used for quick identification and distinguishment of patients with COVID-19.

Acting Ambassador of the Sri Lankan Embassy in China, K.K.Yeganadan, sent a thank-you leter

After the outbreak of COVID-19, Hybribio developed COVID-19 diagnostic kits and has obtained European Union CE certification and Brazil ANVISA certification. Hybribio actively assumed corporate responsibility for in vitro diagnostics and demonstrated Chinese people’s responsibility through provide scientific and technological support for prevention and control of the pandemic. At the same time, many Hybribio medical laboratories in China have passed the EQA of COVID-19 host by the national laboratory and Shanghai Clinical Inspection Centre respectively, and was designated by the local health committee as the designated organization for the detection of COVID-19. Relying on its professional capabilities such as testing capabilities and logistics networks, Hybribio Medical will assist all regions in carrying out normalized prevention and control work, and help large-scale COVID-19 testing nationwide.